IRIS Accounts Production v25.1.4.42 13577568 Board of Directors 30.9.24 1.10.23 30.9.24 30.9.24 Medium entities These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. true true false true true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordianry C 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh135775682023-09-30135775682024-09-30135775682023-10-012024-09-30135775682022-09-30135775682022-10-012023-09-30135775682023-09-3013577568ns15:EnglandWales2023-10-012024-09-3013577568ns14:PoundSterling2023-10-012024-09-3013577568ns10:Director12023-10-012024-09-3013577568ns10:Consolidated2024-09-3013577568ns10:ConsolidatedGroupCompanyAccounts2023-10-012024-09-3013577568ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3013577568ns10:Consolidatedns10:MediumEntities2023-10-012024-09-3013577568ns10:Consolidatedns10:Audited2023-10-012024-09-3013577568ns10:Medium-sizedCompaniesRegimeForDirectorsReport2023-10-012024-09-3013577568ns10:Medium-sizedCompaniesRegimeForAccounts2023-10-012024-09-3013577568ns10:Consolidated2023-10-012024-09-3013577568ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForDirectorsReport2023-10-012024-09-3013577568ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForAccounts2023-10-012024-09-3013577568ns10:FullAccounts2023-10-012024-09-3013577568ns10:OrdinaryShareClass12023-10-012024-09-3013577568ns10:OrdinaryShareClass22023-10-012024-09-3013577568ns10:OrdinaryShareClass32023-10-012024-09-3013577568ns10:Director22023-10-012024-09-3013577568ns10:Director32023-10-012024-09-3013577568ns10:RegisteredOffice2023-10-012024-09-3013577568ns10:Consolidated2022-10-012023-09-3013577568ns5:CurrentFinancialInstruments2024-09-3013577568ns5:CurrentFinancialInstruments2023-09-3013577568ns5:ShareCapital2024-09-3013577568ns5:ShareCapital2023-09-3013577568ns5:RetainedEarningsAccumulatedLosses2024-09-3013577568ns5:RetainedEarningsAccumulatedLosses2023-09-3013577568ns5:ShareCapital2022-09-3013577568ns5:RetainedEarningsAccumulatedLosses2022-09-3013577568ns5:RetainedEarningsAccumulatedLosses2022-10-012023-09-3013577568ns5:RetainedEarningsAccumulatedLosses2023-10-012024-09-3013577568ns5:LandBuildingsns5:OwnedOrFreeholdAssets2023-10-012024-09-3013577568ns5:PlantMachinery2023-10-012024-09-3013577568ns5:FurnitureFittings2023-10-012024-09-3013577568ns5:MotorVehicles2023-10-012024-09-3013577568ns5:CostValuation2023-09-3013577568ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3013577568ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3013577568ns10:OrdinaryShareClass12024-09-3013577568ns10:OrdinaryShareClass22024-09-3013577568ns10:OrdinaryShareClass32024-09-3013577568ns5:RetainedEarningsAccumulatedLosses2023-09-30
REGISTERED NUMBER: 13577568 (England and Wales)
















HEALTHCARE INVESTMENT GROUP LIMITED

GROUP STRATEGIC REPORT,

REPORT OF THE DIRECTORS AND

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024






HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Company Information 1

Group Strategic Report 2

Report of the Directors 4

Report of the Independent Auditors 6

Consolidated Income Statement 9

Consolidated Other Comprehensive Income 10

Consolidated Balance Sheet 11

Company Balance Sheet 12

Consolidated Statement of Changes in Equity 13

Company Statement of Changes in Equity 14

Consolidated Cash Flow Statement 15

Notes to the Consolidated Cash Flow Statement 16

Notes to the Consolidated Financial Statements 17


HEALTHCARE INVESTMENT GROUP LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: S Thorp
C Thorp
S Richards





REGISTERED OFFICE: 2 Lakeview Stables
Lower St. Clere
Kemsing
Sevenoaks
Kent
TN15 6NL





REGISTERED NUMBER: 13577568 (England and Wales)





AUDITORS: Lakeview Southern Audit Limited
Chartered Accountants and
Statutory Auditors
2 Lakeview Stables
Lower St. Clere
Kemsing
Sevenoaks
Kent
TN15 6NL

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2024


The directors present their strategic report of the company and the group for the year ended 30 September 2024.

FAIR REVIEW OF BUSINESS
Healthcare Investment Group Ltd is the holding company for The Superior Healthcare Group Holdings Ltd and its subsidiaries The Superior Healthcare Group Ltd, Superior Nursing Services Ltd, Superior Complex Care Ltd, Superior Specialist Care Ltd and Superior Payroll Ltd, as well as for HRS Healthcare Ltd, Signature Homecare Ltd and The Nurse's Agency Ltd.

The principal activity of the Group's holdings is the provision of specialist, nurse-led care that supports people who have complex, long term health conditions to live safely at home. These services are delivered via The Superior Healthcare Group Ltd and Superior Nursing Services Ltd. Superior Payroll Ltd provided payroll services on behalf of the Group. Superior Complex Care Limited, Superior Specialist Care Limited and Superior Care Ltd were dormant throughout the period.

The Group continued to build upon its specialist care at home services, increasing hours of supply to more than 10,000 hours per week by 30th September 2024. The directors consider the performance of the Group to be satisfactory and believe that our businesses are well placed to grow again in the forthcoming year.

PRINCIPAL RISKS AND UNCERTAINTIES
The directors have identified that the business is exposed to the following risks:

Loss of registration
The Superior Healthcare Group Ltd's services are regulated by the Care Quality Commission and failure to comply with the CQC regulations could impact the Company's ability to provide our services. The directors seek to maintain compliance with the regulations through ongoing monitoring and internal assessment of compliance with statutory regulations. The current rating awarded to The Superior Healthcare Group Ltd by the Care Quality Commission is Good.

Loss of contract
The Group works extensively with NHS ICBs which continue to combine to create a smaller number of commissioning organisations. The directors seek to mitigate exposure to any single ICB through expansion of our geographic footprint and continued diversification of our client base.

Recruitment and employee retention
The Group's ability to deliver and grow its services depends upon the continued growth of our skilled team of carers and nurses. The Group invests heavily to both retain valued members of our team and to attract new employees to our businesses - not least by offering competitive rates of pay, prompt, regular and accurate payment of wages and an increasing range of employee benefits and wellbeing initiatives. Through its subsidiaries, the Group employs an in house team of trainers and clinical educators and offers funded diplomas and additional training opportunities to support employees to progress their careers.

Financial risk management
Credit risk - the principal credit risk arises from the Group's trade debtors. In order to manage credit risk, the Group reviews payment history, third party credit references, debt ageing and collection history on a regular basis.
Interest rate risk - the directors do not consider that the Group is materially exposed to the risk of interest rate rises.
Liquidity risk - the Group ensures that it has sufficient cash to meet the needs of the business through weekly cash forecasting and has effective, long-standing arrangements to support the working capital requirements of the business.

IT systems
The Group's operations depend upon a number of cloud-based IT systems. The directors ensure the security of our systems and data through the procurement of dedicated support contracts.


HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2024

KEY PERFORMANCE INDICATORS
The directors use a range of financial and non-financial key performance indicators to monitor the performance of the business and, in particular, monitors the following KPIs:

2024 2023 Change
Average number of care hours fulfilled weekly: 12,639 £12,573 - %
Average weekly sales: £448,639 £404,574 + 11%
Average number of carers and nurses paid weekly: 455 445 + 2%
Average weekly working hours per carer and nurse: 28 27 - %

FUTURE DEVELOPMENTS
Since 30th September 2024, the Group continues to experience significant demand for our services. Our ability to fulfil the demands of our existing and prospective clients depends upon our ability to attract new people to the Group and to ensure a high rate of retention and engagement amongst our existing team. These continue to be our priorities for the year ahead.

The directors aim to continue to grow our businesses at a sustainable rate which ensures the quality of service that the people that we support rightly expect and to promote an environment in which our employees have the opportunity to thrive.

ON BEHALF OF THE BOARD:





S Thorp - Director


17 June 2025

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


The directors present their report with the financial statements of the company and the group for the year ended 30 September 2024.

PRINCIPAL ACTIVITIES
The principal activities of the group in the year under review were those of the provision of care services within the welfare sector.

DIVIDENDS
The total distribution of dividends for the year ended 30th September 2024 will be £1,588,942 (2023 - £1,195,395).

DIRECTORS
The directors shown below have held office during the whole of the period from 1 October 2023 to the date of this report.

S Thorp
C Thorp
S Richards

FINANCIAL INSTRUMENTS
The company has basic financial debt instruments which are all measured at cost. These include trade debtors, other debtors, cash at bank, trade creditors and other creditors.

EMPLOYEE ENGAGEMENT STATEMENT
Employee engagement is key to the Group's ability to attract and retain our employees and to the Group's overall success. The Group goes to significant lengths to provide a great working experience for colleagues including by providing an open and transparent working environment in which news and developments are shared. The Group provides structured as well as ad-hoc supervision sessions for employees and opportunities for our employees to develop their career prospects through providing access to ongoing training including apprenticeships. The Group has achieved significant successes through the promotion of longstanding employees; all career opportunities are advertised internally and promotions are celebrated by the business.

The Group employs a dedicated wellbeing team and provides all employees access to an employee assistance programme which includes providing access to counselling sessions where events in our employees' lives including homelives lead them to require extra support.

We fundamentally understand that our clients' wellbeing and the Group's success depends upon our people - and recognise our employees as our most valuable asset. To that end, the Group and directors are committed to finding opportunities to continually improve our employees' experience of working for us - and continue to evaluate our success in this area through regular employee surveys, supervision sessions and by providing other opportunities for employees to offer feedback and suggestions.

DISABLED PERSONS
Applications for employment by disabled persons will always be fully and proactively considered. In the event that employees become disabled, every effort is made to ensure that their employment within the Group continues and that appropriate support is offered and adjustments, made. It is the Group's policy that the training, career development and promotion of disabled people should, as far as possible, be identical to that of other employees.

MATTERS COVERED IN THE STRATEGIC REPORT
Information in respect of the business review, future developments, post balance sheet events, financial risk management and exposure to risks are not shown in the Directors' Report because they are presented in the Strategic Report in accordance with s414c(ii) of the Companies Act 2006.


HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the Company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

AUDITORS
The auditors, Lakeview Southern Audit Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





S Thorp - Director


17 June 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
HEALTHCARE INVESTMENT GROUP LIMITED


Opinion
We have audited the financial statements of Healthcare Investment Group Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 30 September 2024 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 30 September 2024 and of the group's profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
HEALTHCARE INVESTMENT GROUP LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We considered the central laws and regulations to the entity and identified those being of significance. We undertook an enquiry of management and those charged with governance to evaluate those of significance and any instances of non-compliance.

Through discussion and, where appropriate, written representation we obtained an understanding of the entity's policies and procedures in relation to fraud risks, including knowledge of any actual, suspected or alleged fraud.

The Senior Statutory Auditor has assessed that the engagement team collectively have the appropriate competence and capabilities to identify or recognise non-compliance with laws and regulations within the areas that they are responsible for testing.

Where necessary, documentation scrutiny was used to determine the significance of any instances with non-compliance of central laws and regulations and reviewed disclosures made in the financial statements to ensure these were appropriately made. We also reviewed the journals processed by the finance team and reviewed all transactions outside the normal course of the entity's business.

We communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.
Irregularities that result from fraud are inherently more difficult to detect from irregularities that result from error.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
HEALTHCARE INVESTMENT GROUP LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Adrian Hull (Senior Statutory Auditor)
for and on behalf of Lakeview Southern Audit Limited
Chartered Accountants and
Statutory Auditors
2 Lakeview Stables
Lower St. Clere
Kemsing
Sevenoaks
Kent
TN15 6NL

17 June 2025

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

CONSOLIDATED INCOME STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   

TURNOVER 3 23,393,295 21,095,651

Cost of sales 14,335,100 13,018,113
GROSS PROFIT 9,058,195 8,077,538

Administrative expenses 6,702,016 5,768,612
OPERATING PROFIT 5 2,356,179 2,308,926

Interest receivable and similar income 147 -
2,356,326 2,308,926

Interest payable and similar expenses 6 28,267 2,383
PROFIT BEFORE TAXATION 2,328,059 2,306,543

Tax on profit 7 592,444 535,068
PROFIT FOR THE FINANCIAL YEAR 1,735,615 1,771,475
Profit attributable to:
Owners of the parent 1,735,615 1,771,475

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

CONSOLIDATED OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   

PROFIT FOR THE YEAR 1,735,615 1,771,475


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

1,735,615

1,771,475

Total comprehensive income attributable to:
Owners of the parent 1,735,615 1,771,475

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

CONSOLIDATED BALANCE SHEET
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 10 399,321 559,022
Investments 11 - -
399,321 559,022

CURRENT ASSETS
Debtors 12 2,264,248 2,575,985
Cash at bank and in hand 917,416 159,495
3,181,664 2,735,480
CREDITORS
Amounts falling due within one year 13 2,232,086 2,059,597
NET CURRENT ASSETS 949,578 675,883
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,348,899

1,234,905

PROVISIONS FOR LIABILITIES 16 70,873 103,552
NET ASSETS 1,278,026 1,131,353

CAPITAL AND RESERVES
Called up share capital 17 1,209 1,209
Retained earnings 18 1,276,817 1,130,144
SHAREHOLDERS' FUNDS 1,278,026 1,131,353

The financial statements were approved by the Board of Directors and authorised for issue on 17 June 2025 and were signed on its behalf by:





S Thorp - Director


HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

COMPANY BALANCE SHEET
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 10 - -
Investments 11 1,331 1,331
1,331 1,331

CURRENT ASSETS
Debtors 12 550,301 508,480
Cash at bank 246,847 32,429
797,148 540,909
CREDITORS
Amounts falling due within one year 13 247,356 2
NET CURRENT ASSETS 549,792 540,907
TOTAL ASSETS LESS CURRENT
LIABILITIES

551,123

542,238

CAPITAL AND RESERVES
Called up share capital 17 1,209 1,209
Retained earnings 18 549,914 541,029
SHAREHOLDERS' FUNDS 551,123 542,238

Company's profit for the financial year 1,597,827 1,586,424

The financial statements were approved by the Board of Directors and authorised for issue on 17 June 2025 and were signed on its behalf by:





S Thorp - Director


HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 SEPTEMBER 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 October 2022 1,209 554,064 555,273

Changes in equity
Dividends - (1,195,395 ) (1,195,395 )
Total comprehensive income - 1,771,475 1,771,475
Balance at 30 September 2023 1,209 1,130,144 1,131,353

Changes in equity
Dividends - (1,588,942 ) (1,588,942 )
Total comprehensive income - 1,735,615 1,735,615
Balance at 30 September 2024 1,209 1,276,817 1,278,026

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 SEPTEMBER 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 October 2022 1,209 150,000 151,209

Changes in equity
Dividends - (1,195,395 ) (1,195,395 )
Total comprehensive income - 1,586,424 1,586,424
Balance at 30 September 2023 1,209 541,029 542,238

Changes in equity
Dividends - (1,588,942 ) (1,588,942 )
Total comprehensive income - 1,597,827 1,597,827
Balance at 30 September 2024 1,209 549,914 551,123

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

CONSOLIDATED CASH FLOW STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 2,927,720 1,060,713
Interest paid - (2,314 )
Finance costs paid (28,267 ) (69 )
Tax paid (531,433 ) (357,054 )
Net cash from operating activities 2,368,020 701,276

Cash flows from investing activities
Purchase of tangible fixed assets (30,114 ) (315,506 )
Sale of tangible fixed assets 8,810 1,160
Interest received 147 -
Net cash from investing activities (21,157 ) (314,346 )

Cash flows from financing activities
Equity dividends paid (1,588,942 ) (1,195,395 )
Net cash from financing activities (1,588,942 ) (1,195,395 )

Increase/(decrease) in cash and cash equivalents 757,921 (808,465 )
Cash and cash equivalents at beginning of
year

2

159,495

967,960

Cash and cash equivalents at end of year 2 917,416 159,495

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

30.9.24 30.9.23
£    £   
Profit before taxation 2,328,059 2,306,543
Depreciation charges 184,082 189,782
Profit on disposal of fixed assets (3,076 ) (1,160 )
Finance costs 28,267 2,383
Finance income (147 ) -
2,537,185 2,497,548
Decrease/(increase) in trade and other debtors 311,737 (642,505 )
Increase/(decrease) in trade and other creditors 78,798 (794,330 )
Cash generated from operations 2,927,720 1,060,713

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 30 September 2024
30.9.24 1.10.23
£    £   
Cash and cash equivalents 917,416 159,495
Year ended 30 September 2023
30.9.23 1.10.22
£    £   
Cash and cash equivalents 159,495 967,960


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.10.23 Cash flow At 30.9.24
£    £    £   
Net cash
Cash at bank and in hand 159,495 757,921 917,416
159,495 757,921 917,416
Total 159,495 757,921 917,416

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

Healthcare Investment Group Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Basis of consolidation
The group financial statements have been prepared under merger accounting which meets the requirements under FRS 102 19.27.

All subsidiaries are 100% owned and therefore fully controlled and required to be fully consolidated.

Revenue recognition
Turnover is measured at the fair of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

All income is recorded in the period in which the care is physically carried out.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Leasehold improvements - 10% on cost
Office equipment - 20% on cost
Computer equipment - 33% on cost
Motor vehicles - 25% on reducing balance

Tangible fixed assets are stated at cost less accumulated depreciation.

Assets held under finance leases are depreciated in the same way as owned assets.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual
arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar
debt instrument, those financial instruments are classified as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains and losses relating to financial liabilities are
included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.


HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

3. TURNOVER

The turnover and profit before taxation are attributable to the principal activities of the group.

An analysis of turnover by class of business is given below:

30.9.24 30.9.23
£    £   
Nursing Services 23,231,375 21,050,530
Recruitment Services 161,920 45,121
23,393,295 21,095,651

An analysis of turnover by geographical market is given below:

30.9.24 30.9.23
£    £   
United Kingdom 23,393,295 21,095,651
23,393,295 21,095,651

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


4. EMPLOYEES AND DIRECTORS
30.9.24 30.9.23
£    £   
Wages and salaries 16,527,462 14,865,504
Social security costs 1,602,871 1,424,784
Other pension costs 269,263 237,461
18,399,596 16,527,749

The average number of employees during the year was as follows:
30.9.24 30.9.23

Direct 492 445
Admin 52 87
Directors 3 3
547 535

The average number of employees by undertakings that were proportionately consolidated during the year was 546 (2023 - 535 ) .

30.9.24 30.9.23
£    £   
Directors' remuneration 77,096 70,598

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 1 1

5. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

30.9.24 30.9.23
£    £   
Depreciation - owned assets 184,081 189,783
Profit on disposal of fixed assets (3,076 ) (1,160 )
Auditors' remuneration 20,880 20,880
Auditors' remuneration for non audit work 16,150 21,416

6. INTEREST PAYABLE AND SIMILAR EXPENSES
30.9.24 30.9.23
£    £   
Loan - 2,314
Other interest 28,267 69
28,267 2,383

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
30.9.24 30.9.23
£    £   
Current tax:
UK corporation tax 625,124 497,684

Deferred tax (32,680 ) 37,384
Tax on profit 592,444 535,068

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

30.9.24 30.9.23
£    £   
Profit before tax 2,328,059 2,306,543
Profit multiplied by the standard rate of corporation tax in the UK of 25 %
(2023 - 25 %)

582,015

576,636

Effects of:
Expenses not deductible for tax purposes 7,816 7,319
Capital allowances in excess of depreciation and net of deferred tax movement
2,769

18,767
Effect of changes in corporation tax rates (156 ) (67,654 )
Total tax charge 592,444 535,068

8. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


9. DIVIDENDS
30.9.24 30.9.23
£    £   
Ordinary A shares of £1 each
Interim - 100,000
Ordinary B share of £1
Interim 280,000 88,982
Ordianry C shares of £1 each
Interim 1,308,942 1,006,413
1,588,942 1,195,395

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


10. TANGIBLE FIXED ASSETS

Group
Leasehold Office Computer Motor
improvements equipment equipment vehicles Totals
£    £    £    £    £   
COST
At 1 October 2023 294,470 682,511 286,311 85,472 1,348,764
Additions 7,048 5,111 17,955 - 30,114
Disposals - - - (11,897 ) (11,897 )
At 30 September 2024 301,518 687,622 304,266 73,575 1,366,981
DEPRECIATION
At 1 October 2023 134,020 371,352 223,535 60,835 789,742
Charge for year 27,083 119,187 32,471 5,340 184,081
Eliminated on disposal - - - (6,163 ) (6,163 )
At 30 September 2024 161,103 490,539 256,006 60,012 967,660
NET BOOK VALUE
At 30 September 2024 140,415 197,083 48,260 13,563 399,321
At 30 September 2023 160,450 311,159 62,776 24,637 559,022

11. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 October 2023
and 30 September 2024 1,331
NET BOOK VALUE
At 30 September 2024 1,331
At 30 September 2023 1,331

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


11. FIXED ASSET INVESTMENTS - continued

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiaries

The Superior Healthcare Group Holdings Ltd
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Holding Company
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 1,209 1,209
Profit for the year 1,700,000 1,600,000

The Superior Healthcare Group Ltd
Registered office: Gazette House 5-8 Estuary View Business Park, Boorman Way, Whitstable, Kent, England, CT5 3SE
Nature of business: Nursing Services
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 615,732 583,793
Profit for the year 2,221,745 921,310

Superior Nursing Services Ltd
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Nursing Services
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 138,937 35,194
Profit for the year 205,887 1,427,352

Superior Payroll Ltd
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Payroll services
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 120 120

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


11. FIXED ASSET INVESTMENTS - continued

Superior Complex Care Limited
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Dormant Company
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 1 1

This entity is exempt from audit by virtue of S479A Companies Act 2006 and exempt from preparing individual accounts by virtue of S479A Companies Act 2006.

Superior Specialist Care Limited
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Dormant Company
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 120 120

This entity is exempt from audit by virtue of S479A Companies Act 2006 and exempt from preparing individual accounts by virtue of S479A Companies Act 2006.

Signature Homecare Limited
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Dormant Company
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 1 1

This entity is exempt from audit by virtue of S479A Companies Act 2006 and exempt from preparing individual accounts by virtue of S479A Companies Act 2006.

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


11. FIXED ASSET INVESTMENTS - continued

The Nurse's Agency Limited
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Dormant Company
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 1 1

This entity is exempt from audit by virtue of S479A Companies Act 2006 and exempt from preparing individual accounts by virtue of S479A Companies Act 2006.

HRS Healthcare Ltd
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Recruitment Services
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves (26,317 ) (28,423 )
Profit/(loss) for the year 2,600 (28,543 )

Superior Care Limited
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Dormant Company
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 2 2

This entity is exempt from audit by virtue of S479A Companies Act 2006 and exempt from preparing individual accounts by virtue of S479A Companies Act 2006.


12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
30.9.24 30.9.23 30.9.24 30.9.23
£    £    £    £   
Trade debtors 1,419,240 1,903,442 - -
Amounts owed by group undertakings - - 550,301 508,480
Amounts recoverable on contract 542,006 399,635 - -
Other debtors 500 100 - -
Prepayments 302,502 272,808 - -
2,264,248 2,575,985 550,301 508,480

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR - continued

Amounts owed by group undertakings are repayable on demand.

13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
30.9.24 30.9.23 30.9.24 30.9.23
£    £    £    £   
Trade creditors 228,701 176,928 2,000 -
Amounts owed to group undertakings - - 43,721 2
Tax 591,375 497,684 - -
Social security and other taxes 343,584 369,460 - -
Other creditors 934,034 934,338 200,921 -
Accruals and deferred income 134,392 81,187 714 -
2,232,086 2,059,597 247,356 2

Amounts owed to group undertakings are repayable on demand.

14. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Non-cancellable operating leases
30.9.24 30.9.23
£    £   
Within one year 252,229 241,489
Between one and five years 545,789 243,268
798,018 484,757

15. SECURED DEBTS

The following secured debts are included within creditors:

Group
30.9.24 30.9.23
£    £   
Invoice discounting facility - 263,592

The invoice discounting facility is secured by a debenture over the assets of The Superior Healthcare Group Ltd. The debenture contains both fixed and floating charges. The floating charge covers all the property or undertaking of The Superior Healthcare Group Ltd.

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


16. PROVISIONS FOR LIABILITIES

Group
30.9.24 30.9.23
£    £   
Deferred tax 70,873 103,552

Group
Deferred
tax
£   
Balance at 1 October 2023 103,552
Provided during year (32,679 )
Balance at 30 September 2024 70,873

17. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
1,200 Ordinary A £1 1,200 1,200
1 Ordinary B £1 1 1
8 Ordianry C £1 8 8
1,209 1,209

The ordinary A shares have voting rights, an entitlement to dividends and an entitlement to distribution on liquidation or sale.

The ordinary B shares hold no voting rights, have an entitlement to dividends, and will have no rights over surplus assets or proceeds should the company be liquidated or sold.

The ordinary C shares hold no voting rights, have an entitlement to dividends, and will have no rights over surplus assets or proceeds should the company be liquidated or sold.

18. RESERVES

Group
Retained
earnings
£   

At 1 October 2023 1,130,144
Profit for the year 1,735,615
Dividends (1,588,942 )
At 30 September 2024 1,276,817

HEALTHCARE INVESTMENT GROUP LIMITED (REGISTERED NUMBER: 13577568)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


18. RESERVES - continued

Company
Retained
earnings
£   

At 1 October 2023 541,029
Profit for the year 1,597,827
Dividends (1,588,942 )
At 30 September 2024 549,914

The retained earnings is the cumulative profit and loss net of distributions.

19. PENSION COMMITMENTS

The group makes contributions to a defined contribution pension scheme. During the year contributions of £238,819 (2022: £185,298) were paid by the group. The contributions due are those specified under the legal requirements of Auto-enrolment. The cost of these contributions are charged to the statement of comprehensive income on an accruals basis as they become payable under the scheme.

20. RELATED PARTY DISCLOSURES

The company was owed £Nil (2023: £504,647) from The Superior Healthcare Group Holdings Ltd, £50,301 (2023:£3,833) from HRS Healthcare Ltd, £50,000 (2023: £Nil) from Superior Nursing Services Ltd and £450,000 (2023: £Nil) from The Superior Healthcare Group Ltd at 30 September 2024.

The company owed £1 (2023: £1) to The Nurse's Agency Limited and £1 (2023: £1) to Signature Homecare Limited and £43,719 to Superior Payroll Ltd (2023: £Nil).

During the year the company received £200,000 loan from a related party and interest is being charged at 7.25%.

During the year Healthcare Investment Group Limited received dividends of £1,700,000 (2023: £1,600,000) from The Superior Healthcare Group Holdings Ltd.

21. ULTIMATE CONTROLLING PARTY

The ultimate controlling parties are S Thorp and C Thorp.

22. PRINCIPAL PLACE OF BUSINESS

The principal place of business is Gazette House, 5-8 Estuary View Business Park, Boorman Way, Whitstable, Kent CT5 3SE.

23. GROUP

Healthcare Investment Group Ltd holds the entire issued share capital of Signature Homecare Ltd, The Nurse's Agency Ltd, HRS Healthcare Ltd and The Superior Healthcare Group Holdings Ltd.

The Superior Healthcare Group Holdings Ltd holds the entire issued share capital of The Superior Healthcare Group Ltd, Superior Nursing Services Ltd, Superior Complex Care Ltd, Superior Specialist Care Ltd and Superior Payroll Ltd.